The FDA Amendments Act: Reauthorization of the FDA

被引：0

作者：

von Eschenbach, Andrew C. ^{[1
]}

机构：

[1] US FDA, Rockville, MD 20857 USA

来源：

FOOD AND DRUG LAW JOURNAL | 2008年 / 63卷 / 02期

关键词：

D O I：

暂无

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

引用

页码：579 / 584

页数：6

共 50 条

[1] Increasing transparency at the FDA: The impact of the FDA Amendments Act of 2007
Wood, Susan F.
Perosino, Kristen L.
[J]. PUBLIC HEALTH REPORTS, 2008, 123 (04) : 527 - 530
[2] Closing a loophole in the FDA Amendments Act
Zarin, Deborah A.
Tse, Tony
[J]. SCIENCE, 2008, 322 (5898) : 45 - 46
[3] FDA prepares for PDUFA reauthorization
不详
[J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (05) : 349 - 349
[4] The US Congress has passed the FDA Amendments Act of 2007
[J]. Reactions Weekly, 2007, 1171 (1) : 3 - 3
[5] Has the FDA Amendments Act of 2007 Impaired Drug Development?
Franson, T. R.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (02) : 169 - 171
[6] US FDA review and regulation of preventive vaccines for infectious disease indications: impact of the FDA Amendments Act 2007
Gruber, Marion F.
[J]. EXPERT REVIEW OF VACCINES, 2011, 10 (07) : 1011 - 1019
[7] Superfund Amendments and Reauthorization Act of 1986 (SARA).
Bennett, DA
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 11 - CHAS
[8] Overview of the FDA Amendments Act of 2007: Its Effect on the Drug Development Landscape
Kishore, Raj
Tabor, Edward
[J]. DRUG INFORMATION JOURNAL, 2010, 44 (04): : 469 - 475
[9] Overview of the FDA Amendments Act of 2007: Its Effect on the Drug Development Landscape
Raj Kishore
Edward Tabor
[J]. Drug information journal : DIJ / Drug Information Association, 2010, 44 (4): : 469 - 475
[10] Trial results reporting: FDA Amendments Act Final Rule needs enforcement
von Elm, Erik
Meerpohl, Joerg J.
[J]. LANCET, 2020, 395 (10221): : 316 - 317

← 1 2 3 4 5 →